QUADRANT CAPITAL GROUP LLC - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 134 filers reported holding KURA ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 8.88 and the average weighting 0.3%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$438
+129.3%
48
+166.7%
0.00%
Q2 2023$191
-98.9%
18
-98.7%
0.00%
-100.0%
Q1 2023$16,964
+1596.4%
1,387
+2567.3%
0.00%
Q2 2022$1,0000.0%52
-14.8%
0.00%
Q1 2022$1,00061
+281.2%
0.00%
Q1 2020$0160.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,849,947$16,871,5179.37%
Prosight Management, LP 1,932,456$17,623,9995.58%
ACUTA CAPITAL PARTNERS, LLC 702,093$6,403,0884.29%
ALETHEA CAPITAL MANAGEMENT, LLC 350,445$3,196,0583.93%
SUVRETTA CAPITAL MANAGEMENT, LLC 7,335,845$66,902,9063.62%
Affinity Asset Advisors, LLC 856,535$7,811,5992.20%
TCG Crossover Management, LLC 1,423,642$12,983,6151.91%
EcoR1 Capital, LLC 5,806,871$52,958,6641.79%
BVF INC/IL 6,730,983$61,386,5651.66%
DAFNA Capital Management LLC 550,784$5,023,1501.56%
View complete list of KURA ONCOLOGY INC shareholders